Literature DB >> 20200625

Inflammation, high-sensitivity C-reactive protein, and vascular protection.

Paul M Ridker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20200625      PMCID： PMC2829802     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  8 in total

1.  Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study.

Authors:  Robert J Glynn; Jean G MacFadyen; Paul M Ridker
Journal:  Clin Chem       Date:  2008-12-18       Impact factor: 8.327

Review 2.  2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

Authors:  Jacques Genest; Ruth McPherson; Jiri Frohlich; Todd Anderson; Norm Campbell; André Carpentier; Patrick Couture; Robert Dufour; George Fodor; Gordon A Francis; Steven Grover; Milan Gupta; Robert A Hegele; David C Lau; Lawrence Leiter; Gary F Lewis; Eva Lonn; G B John Mancini; Dominic Ng; Glen J Pearson; Allan Sniderman; James A Stone; Ehud Ur
Journal:  Can J Cardiol       Date:  2009-10       Impact factor: 5.223

3.  Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.

Authors:  Mevlut Koc; Osman Karaarslan; Gulcan Abali; Mustafa Kemal Batur
Journal:  Tex Heart Inst J       Date:  2010

Review 4.  Impact of C-reactive protein on in-stent restenosis: a meta-analysis.

Authors:  Jian-Jun Li; Yi Ren; Ke-Ji Chen; Alan C Yeung; Bo Xu; Xin-Min Ruan; Yue-Jin Yang; Ji-Lin Chen; Run-Lin Gao
Journal:  Tex Heart Inst J       Date:  2010

5.  Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.

Authors:  P M Ridker; J E Manson; J E Buring; J E Muller; C H Hennekens
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

6.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  N Engl J Med       Date:  2008-11-09       Impact factor: 91.245

Review 7.  Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).

Authors:  Paul M Ridker
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

8.  National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease.

Authors:  Gary L Myers; Robert H M Christenson; Mary Cushman; Christie M Ballantyne; Gerald R Cooper; Christine M Pfeiffer; Scott M Grundy; Darwin R Labarthe; Daniel Levy; Nader Rifai; Peter W F Wilson
Journal:  Clin Chem       Date:  2008-12-23       Impact factor: 8.327
  8 in total
  3 in total

1.  Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans.

Authors:  Jaclyn Ellis; Ethan M Lange; Jin Li; Josee Dupuis; Jens Baumert; Jeremy D Walston; Brendan J Keating; Peter Durda; Ervin R Fox; Cameron D Palmer; Yan A Meng; Taylor Young; Deborah N Farlow; Renate B Schnabel; Carola S Marzi; Emma Larkin; Lisa W Martin; Joshua C Bis; Paul Auer; Vasan S Ramachandran; Stacey B Gabriel; Monte S Willis; James S Pankow; George J Papanicolaou; Jerome I Rotter; Christie M Ballantyne; Myron D Gross; Guillaume Lettre; James G Wilson; Ulrike Peters; Wolfgang Koenig; Russell P Tracy; Susan Redline; Alex P Reiner; Emelia J Benjamin; Leslie A Lange
Journal:  Hum Genet       Date:  2014-03-19       Impact factor: 4.132

Review 2.  Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2010-12-09       Impact factor: 4.162

Review 3.  Recent advances in the management of chronic stable angina I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.